ANP 17.9% 3.3¢

ANTISENSE THERAPEUTICS LIMITED

Market Cap $11.14M Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Latest Threads

Tag

Subject

ANP

Ann: Phase II clinical trial in DMD Update

16:41

2.0K

16:41

Last post itsagas

2.0K

ANP

Antisense Theraputics takes a foothold in USA DMD community

17/01/19

1.5K

17/01/19

Last post the Zig

1.5K

ANP

Chart

3 4 5

09/01/19

290

62K

09/01/19

Last post Mr Jones

290

62K

ANP

Oblivion’s Bin

06/01/19

884

06/01/19

Last post imperatore

884

ANP

SBS News

03/01/19

1.1K

03/01/19

Last post Steadfast

1.1K

ANP

Biotech’ media.

26/12/18

5.2K

26/12/18

Last post the Zig

5.2K

ANP

Ann: AGM Presentation

14/12/18

10K

14/12/18

Last post flex76

10K

ANP

Ann: Receipt of R&D Tax Incentive payment

07/12/18

4.6K

07/12/18

Last post Upxdn

4.6K

See All Discussions

Timeline

Phase II clinical trial in DMD Update
18 Jan 09:03	Share

Receipt of R&D Tax Incentive payment
04 Dec 08:57	Share

Results of Meeting
29 Nov 12:52	Share

AGM Presentation
29 Nov 11:01	Share

Appendix 4G
09 Nov 11:12	Share

Change of Director's Interest Notice (RM)
02 Nov 17:41	Share

Change of Director's Interest Notice (MD)
02 Nov 17:39	Share

Investor Presentation
30 Oct 09:12	Share

Notice of Annual General Meeting/Proxy Form
29 Oct 09:41	Share

Appendix 4C - quarterly
29 Oct 09:30	Share

Response to ASX Price and Volume Query
16 Oct 15:04	Share

Duchenne ACTT Now Conference 2018
06 Sep 09:15	Share

Full Year Statutory Accounts
29 Aug 16:26	Share

First Patient Dosed in Phase II DMD Clinical Trial
29 Aug 10:38	Share

Pause in Trading
29 Aug 10:10	Share

ANP to Present at 14th Annual Bioshares Biotech Summit
27 Jul 09:37	Share

Change of Director's Interest Notice (RM)
26 Jul 09:32	Share

Appendix 4C - quarterly
24 Jul 19:19	Share

Company Appointment
23 Jul 09:10	Share

ANP initiates ATL1102 Phase II clinical trial in DMD
16 Jul 09:35	Share

Appendix 3B
28 Jun 15:09	Share

121 Tech Investment Hong Kong Conference Presentation
14 Jun 10:04	Share

ATL1103/atesidorsen Early Access Program Progress Update
14 Jun 09:53	Share

Change of Director's Interest Notice - WG
01 Jun 11:30	Share

ATL1103 Phase II trial results published in leading journal
23 May 09:56	Share

Response to ASX Price & Volume Query
14 May 10:05	Share

Ceasing to be a substantial holder from OPT
11 May 16:49	Share

Change of Director's Interest Notice - (RM, MD, GP, WG, GM)
09 May 15:44	Share

Appendix 3B - Completion of Allotment
09 May 15:35	Share

Becoming a substantial holder
09 May 09:50	Share

View More

(20min delay) Trade with IG
Last 3.3¢		Change 0.01(17.9%)		Mkt cap $11.14M

Open	High	Low	Value	Volume
3.2¢	3.4¢	2.8¢	$41.89K	1.334M

Buyers (Bids)

No.	Vol.	Price($)
2	157948	3.1¢

Sellers (Offers)

Price($)	Vol.	No.
3.4¢	316076	3

Last update - 15.56pm 18/01/2019 (20 minute delay)

(live)
Last 3.1¢		Change 0.01 ( 10.7 %)
Open	High	Low	Volume
2.9¢	3.3¢	2.9¢	329246
Last updated 15.58pm 18/01/2019 (live) ?

ANP (ASX) Chart